...
首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >A Systematic Review of the Effectiveness of Oral Baclofen in the Management of Hiccups in Adult Palliative Care Patients
【24h】

A Systematic Review of the Effectiveness of Oral Baclofen in the Management of Hiccups in Adult Palliative Care Patients

机译:对成人姑息治疗患者杂交中的口腔培养物疗效的系统综述

获取原文
获取原文并翻译 | 示例
           

摘要

Hiccup is a recognised symptom amongst the palliative care population. It can be debilitating, with significant impact on quality of life. The pathophysiology is poorly understood and the list of aetiological factors is extensive. The current treatment recommendations are based on a small body of evidence and there remains uncertainty regarding optimal management. The aim of this study was to systematically review the evidence for oral baclofen in the management of hiccups in adult palliative care patients. A search was conducted using MEDLINE, Embase, the Cochrane library and CINAHL, as well as a hand search and review of the grey literature. Relevant articles were identified using pre-defined eligibility criteria. Quality assessment was guided by the SIGN grading system, CASP, Hawker et al's checklist and Cochrane's risk of bias tool. A narrative approach was used for data synthesis. Four relevant articles were identified; one randomised controlled trial and three case series. This gave a combined total of 22 patients, all of whom benefited from the use of oral baclofen in the treatment of hiccups, with few reports of side effects. The dose ranged from 10mg once only to 20mg TDS, and the duration from 1-24 days. However, the overall quality of the evidence was low. While baclofen is an option in the management of hiccups, it is difficult to make recommendations based on the body of evidence presented in this systematic review. There is a lack of RCTs in this field and further research is warranted.
机译:HiCcup是姑息治疗人口中公认的症状。它可以衰弱,对生活质量产生重大影响。病理生理学理解得很差,并且Aetiology因素列表是广泛的。目前的治疗建议基于一小部分证据,仍然有关最优管理的不确定性。本研究的目的是系统地审查在成人姑息治疗患者中杂交中的口腔培养物中口服Baclofen的证据。使用Medline,Embase,Cochrane图书馆和Cinahl以及灰色文献的手进行搜索。使用预定义的资格标准识别相关文章。质量评估由标志分级系统,Casp,Hawker等,检查表和Cochrane偏见工具的风险为指导。叙述方法用于数据合成。确定了四篇相关文章;一个随机对照试验和三个案例系列。这给了22例患者的总和,所有这些患者都受益于使用口服乳蛋白治疗打嗝,少数副作用报告。剂量从10mg次数范围仅为20mg TDS,持续时间为1-24天。但是,证据的整体质量很低。虽然Baclofen是在管理打嗝时的选择,但很难根据本系统审查中提出的证据组成的建议。在这一领域缺乏RCT,并有权进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号